Flu changes, ever so slightly, year by year and region by region. The vaccine manufacturing industry must bring changes of its own.

The Alliance for RTU has been founded to accelerate and improve manufacturing quality, consistency, and regulatory efficiency.

The Nobel Prize for Medicine has again been awarded jointly, this time for miRNA discovery and its role in gene regulation

Biopharma companies procrastinating on sustainability measures risk falling behind, according to Cytiva’ Global Biopharma Sustainability Review.

AstraZeneca’s FluMist is the first flu vaccine to be approved for self-administration.

Researchers use AI to reprogram glioblastoma cancer cells

Ever wondered what the distant future of pharma and healthcare looks like? A group of industry experts offer their sage predictions.

The contribution of macaques to advancing human understanding of flu-like viruses, including H5N1, cannot be overstated.

Research suggests diabetes patients using SGLT-2 and DPP-4 inhibitors have a decreased risk of developing dementia.

Nanorobots developed by engineers from the UK and China have delivered precision treatment to brain aneurysms